These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13093280)

  • 1. [Liver in Flajani-Basedow disease; biopsic study].
    BASEVI A; DAGNINI G
    Arch Patol Clin Med; 1953; 30(6):391-432. PubMed ID: 13093280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathophysiological analysis of the heart in Flajani-Basedow disease].
    BIANCHI C; MERGONI G
    Folia Cardiol; 1947 Nov; 6(4):327-67. PubMed ID: 18906349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological, clinical, therapeutic and evolutive aspects of Basedow-Graves disease in the Depatment of Internal Medicine at CHU Aristide Le Dantec, Dakar (Senegal)].
    Diagne N; Faye A; Ndao AC; Djiba B; Kane BS; Ndongo S; Pouye A
    Pan Afr Med J; 2016; 25():6. PubMed ID: 28154699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on cardiac and arterial system dynamics in m. by Flajani-Basedow using the sphygmographic method, also in relation to antithyroid therapy with methylthiouracil].
    ALTANA G
    Folia Cardiol; 1947 Nov; 6(4):289-302. PubMed ID: 18906347
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of angiotensin-converting enzyme in women with hyperthyroidism accompanying Graves-Basedow disease].
    Zdrojewicz Z
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1004-5. PubMed ID: 1339053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological aspects of Flajani-Graves-Basedow disease].
    Ferrini O; Indiveri F; Barabino A; Masturzo P; Polleri A
    Arch Maragliano Patol Clin; 1973; 29(2):117-35. PubMed ID: 4218073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ocular symptomatology in atypical and unilateral forms of the Flajani-Basedow disease].
    Aliquò-Mazzei A
    Friuli Med; 1964; 19(5):715-56. PubMed ID: 5896862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acromegaly and Graves-Basedow disease. Report of 3 cases].
    Burgos Peláez R; Simó Canonge R; Hernández-Pascual C; Mesa Manteca J
    Med Clin (Barc); 1994 Jul; 103(5):179-80. PubMed ID: 7934281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rarely encountered association of hyperthyroidism in the form of Graves-Basedow disease with vitiligo].
    Hrycek A; Szwed Z; Badowski R
    Wiad Lek; 1994 Mar; 47(5-6):213-5. PubMed ID: 7941564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Probable causal relations between roentgen irradiation in Flajani-Basedow disease and cancer of the larynx].
    GALIOTO GB
    Boll Mal Orecch Gola Naso; 1951; 69(5-6):260-70. PubMed ID: 14858589
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical problems in Basedow's disease].
    TOURNEUR R
    Bull Med; 1953 Apr; 67(7):177-81. PubMed ID: 13066838
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism.
    Rybus-Kalinowska B; Zwirska-Korczala K; Kalinowski M; Kukla M; Birkner E; Jochem J
    Pol Arch Med Wewn; 2008; 118(7-8):420-5. PubMed ID: 18714737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of apathetic form of Graves-Basedow disease with hyperthyroidism].
    Hanzlik J; Ilenda M
    Wiad Lek; 1973 Aug; 26(15):1449-51. PubMed ID: 4740974
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of radiotherapy in hyperthyroidism and in Basedow disease].
    BIANCHI E; GASPARINI S
    Friuli Med; 1956; 11(4):611-34. PubMed ID: 13365794
    [No Abstract]   [Full Text] [Related]  

  • 15. [Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?].
    Fazakas S; Kiss B; Petrányi G
    Orv Hetil; 1972 May; 113(20):1059-61. PubMed ID: 5067474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current problems and prospects of classification of hyperthyroidisms, with special reference to the pathogenesis of Graves-Basedow disease].
    Borghi A; Maiello M
    Riv Crit Clin Med; 1966 Aug; 66(3):205-17. PubMed ID: 6015045
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inconvenience and deficiency of present therapy of Flajani-Basedow syndrome].
    COSTA A; MARCHIS E
    Minerva Med; 1953 Jan; 44(9):241-5. PubMed ID: 13063239
    [No Abstract]   [Full Text] [Related]  

  • 18. [Graves Basedow disease following treatment with magistral formulae for obesity. Jod-Basedow phenomenon?].
    Goday-Arnó A; García Rico A; Martínez-Riquelme A; Cano-Pérez JF
    Rev Clin Esp; 1996 Aug; 196(8):536-8. PubMed ID: 8984540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Free radical concepts in the etiopathogenesis of Graves-Basedow disease].
    Komosińska-Vassev K; Olczyk K; Winsz K
    Postepy Hig Med Dosw; 2000; 54(2):225-37. PubMed ID: 10857382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation process in Flajani-Basedow disease].
    OTTAVIANI P; DETTORI AG
    G Clin Med; 1953 Sep; 34(9):1070-94. PubMed ID: 13128381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.